Leucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritis

• Yuka Shibata,
• Hideki Nakajima,
• Kimiko Nakajima,
• Satoshi Serada,
• Minoru Fujimoto,
• Tetsuji Naka,
• Shigetoshi Sano

Affiliations

Yuka Shibata

783‐8505 Department of Dermatology Kochi Medical School Kochi University Okohcho Japan

Hideki Nakajima

783‐8505 Department of Dermatology Kochi Medical School Kochi University Okohcho Japan

Kimiko Nakajima

783‐8505 Department of Dermatology Kochi Medical School Kochi University Okohcho Japan

Satoshi Serada

783‐8505 Department of Clinical Immunology Kochi Medical School Kochi University Okohcho Japan

Minoru Fujimoto

783‐8505 Department of Clinical Immunology Kochi Medical School Kochi University Okohcho Japan

Tetsuji Naka

783‐8505 Department of Clinical Immunology Kochi Medical School Kochi University Okohcho Japan

Shigetoshi Sano

783‐8505 Department of Dermatology Kochi Medical School Kochi University Okohcho Japan